Evotec (OTCMKTS:EVTCY) Hits New 52-Week Low – Here’s Why

Evotec SE (OTCMKTS:EVTCY) reached a new 52-week low during trading on Tuesday . The company traded as low as $3.90 and last traded at $3.92, with a volume of 92109 shares traded. The stock had previously closed at $3.86.

Evotec Trading Up 1.6 %

The company has a 50-day simple moving average of $3.38 and a 200-day simple moving average of $4.41. The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.50 and a current ratio of 2.57. The stock has a market cap of $1.29 billion, a P/E ratio of 9.41 and a beta of 0.98.

About Evotec

Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.